The way type-2 diabetes is currently treated generates differences of opinion within the medical community. Whilst some favour a drug combination approach that could improve quality of life for patients and reduce costs, others are concerned about the risks and side effects of this strategy and support a step-by-step method whereby one drug is used at a time depending on how the patient responds.
New, first-of-its-kind, large-scale study includes more than 76,000 heart patients.A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation.
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who are considered to be at low risk for stroke may not be effective as previously thought.
The study found that atrial fibrillation patients who received a catheter ablation and were low risk of stroke didn’t benefit from long-term aspirin therapy, but are at risk of higher rates of bleeding compared to no therapy at all.
Heart failure patients readmitted to the same facility spend fewer days in the hospital and are more likely to survive. Time is important when seeking hospital care for acute events like heart attack or stroke, but for treatment of a chronic condition like heart failure, continuity of care seems to be more important, researchers said.
When patients were unaware they were taking statins there was no reported increase in muscle-related symptoms. But, when patients knew they were taking a statin, they were more likely to report symptoms, a finding consistent with the nocebo effect.
Post-partum haemorrhage is the leading cause of maternal death worldwide, responsible for 100,000 deaths per year, the majority in low and middle income countries.
Tranexamic acid – an inexpensive and widely available drug – could reduce maternal deaths among women with severe bleeding after child birth, according to a global trial of 20,000 women in 21 countries, published in The Lancet. The study found that death due to bleeding was reduced by a third if the drug was given within 3 hours of the onset of post-partum haemorrhage.